Breaking News Instant updates and real-time market news.

EOLS

Evolus

$14.20

0.25 (1.79%)

07:24
11/26/19
11/26
07:24
11/26/19
07:24

SVB Leerink 'bullish on aesthetics,' starts Evolus at Outperform

As previously reported, SVB Leerink analyst Marc Goodman initiated coverage of Evolus with an Outperform rating and $25 price target. He is bullish on the sustainable growth of the broader U.S. aesthetics market and specifically believes the neurotoxins market will grow in the 7%-10% range to $2B in 2025. Evolus' Jeuveau is the fourth neurotoxin to enter the U.S. market, but "the first toxin that is really similar" to Allergan's (AGN) Botox, giving it a viable opportunity to become the number two player in the U.S. market in the next few years, Goodman contends. He also likes the management team and expects M&A over time to bring in additional aesthetics products.

EOLS Evolus
$14.20

0.25 (1.79%)

07/31/19
STFL
07/31/19
NO CHANGE
STFL
Buy
Physician survey bodes well for Evolus and Revance, says Stifel
Stifel analyst Annabel Samimy said her survey of 50+ physicians in late June lead her to now believe that new toxins could have penetrations that exceed her current market-share estimates. The survey bodes well for Evolus (EOLS) in the near-term and for both Evolus and Revance (RVNC) in the longer-term while also indicating that Allergan's (AGN) Botox franchise may be more vulnerable than previously thought, Samimy tells investors. She previously had Evolus' Jeuveau reaching a peak market share of 15% and Revance's DaxibotulinumtoxinA reaching 20% shares by 2027, but her new "base case" assumes that Jeuveau peaks at 20% share and Daxi peaks at 25%, noted Samimy, who took down her Botox market share forecast for 2027 to 50%. Samimy raised her price target on Evolus shares to $33 from $30 and keeps a $50 price target on Revance while maintaining Buy ratings on both stocks.
08/13/19
JMPS
08/13/19
NO CHANGE
Target $30
JMPS
Outperform
Evolus price target lowered to $30 from $35 at JMP Securities
JMP Securities analyst Donald Ellis lowered his price target on Evolus to $30 after its Q2 earnings miss and to reflect the updated share count for the stock in his valuation model. The analyst is keeping his Outperform rating however, noting that the company's launch of JEUVEAU on May 15 has exceeded expectations on several metrics, including "physician practices joining the JET trial" and patient satisfaction. Ellis maintains his expectation for JEUVEAU to achieve the management's target of a #2 position in the U.S. aesthetic toxin market.
09/05/19
MZHO
09/05/19
INITIATION
Target $30
MZHO
Buy
Evolus assumed with a Buy at Mizuho
Mizuho analyst Difei Yang assumed coverage of Evolus with an unchanged Buy rating and $30 price target. The company's "innovative" Jeuveau neurotoxin will capture significant share in the "attractive" neurotoxin market, Yang tells investors in a research note.
11/26/19
LEER
11/26/19
INITIATION
Target $25
LEER
Outperform
Evolus initiated with an Outperform at SVB Leerink
SVB Leerink analyst Marc Goodman initiated coverage of Evolus with an Outperform rating and $25 price target.

TODAY'S FREE FLY STORIES

TARO

Taro Pharmaceutical

$93.79

-1.14 (-1.20%)

08:46
12/06/19
12/06
08:46
12/06/19
08:46
Hot Stocks
Taro Pharmaceutical CFO Mariano Balaguer to resign »

Taro Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZM

Zoom Video

$69.73

-0.22 (-0.31%)

08:46
12/06/19
12/06
08:46
12/06/19
08:46
Recommendations
Zoom Video analyst commentary  »

Zoom Video price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

08:45
12/06/19
12/06
08:45
12/06/19
08:45
General news
U.S. nonfarm payrolls surged 266k in November »

U.S. nonfarm payrolls…

HEXO

Hexo

$2.06

-0.075 (-3.52%)

, XNET

Xunlei

$4.93

0.02 (0.41%)

08:45
12/06/19
12/06
08:45
12/06/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

HEXO

Hexo

$2.06

-0.075 (-3.52%)

XNET

Xunlei

$4.93

0.02 (0.41%)

CGC

Canopy Growth

$18.58

0.19 (1.03%)

UPRO

Uproar Inc

$63.22

0.35 (0.56%)

SRNE

Sorrento Therapeutics

$3.25

-0.41 (-11.20%)

VSTM

Verastem

$1.26

-0.115 (-8.39%)

ET

Energy Transfer LP

$11.60

0.29 (2.56%)

TTM

Tata Motors

$11.56

-0.28 (-2.36%)

NIO

NIO Inc.

$2.27

-0.15 (-6.20%)

VAL

Valaris

$4.55

0.12 (2.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 16

    Dec

08:45
12/06/19
12/06
08:45
12/06/19
08:45
General news
FX Action: The dollar »

FX Action: The dollar…

CPST

Capstone Turbine

$3.77

-0.11 (-2.84%)

08:44
12/06/19
12/06
08:44
12/06/19
08:44
Hot Stocks
Capstone Turbine appoints Eric Hencken as CFO »

Capstone Turbine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEMP

Gemphire Therapeutics

$0.33

-0.0068 (-1.99%)

08:44
12/06/19
12/06
08:44
12/06/19
08:44
Hot Stocks
Gemphire announces stockholder approvals required for NeuroBo merger »

Gemphire Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNMA

Fannie Mae

$0.00

(0.00%)

, FMCC

Freddie Mac

$0.00

(0.00%)

08:43
12/06/19
12/06
08:43
12/06/19
08:43
Recommendations
Fannie Mae, Freddie Mac analyst commentary  »

Fannie Mae price target…

FNMA

Fannie Mae

$0.00

(0.00%)

FMCC

Freddie Mac

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKC

Turkcell

$6.04

0.14 (2.37%)

08:41
12/06/19
12/06
08:41
12/06/19
08:41
Hot Stocks
Turkcell signs MoU with China Development Bank »

Turkcell has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZM

Zoom Video

$69.73

-0.22 (-0.31%)

08:41
12/06/19
12/06
08:41
12/06/19
08:41
Recommendations
Zoom Video analyst commentary  »

Zoom Video price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

FMCC

Freddie Mac

$0.00

(0.00%)

08:40
12/06/19
12/06
08:40
12/06/19
08:40
Initiation
Freddie Mac initiated  »

B. Riley FBR sees wide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWI

SolarWinds

$18.42

-0.405 (-2.15%)

08:39
12/06/19
12/06
08:39
12/06/19
08:39
Conference/Events
SolarWinds to host analyst & investor day »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

08:37
12/06/19
12/06
08:37
12/06/19
08:37
Conference/Events
The Washington Journal to hold a discussion »

Representative Henry…

IESC

IES Holdings

$21.85

0.42 (1.96%)

08:36
12/06/19
12/06
08:36
12/06/19
08:36
Earnings
IES Holdings reports Q4 adj. EPS 58c vs. 46c last year »

Reports Q4 revenue $294M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

08:36
12/06/19
12/06
08:36
12/06/19
08:36
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TREE

LendingTree

$354.44

-2.32 (-0.65%)

08:36
12/06/19
12/06
08:36
12/06/19
08:36
Conference/Events
LendingTree to host analyst & investor day »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ISEE

IVERIC bio

$4.32

0.205 (4.98%)

08:34
12/06/19
12/06
08:34
12/06/19
08:34
Syndicate
IVERIC bio 6.25M share Spot Secondary priced at $4.00 »

Cowen acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ALXN

Alexion

$107.42

-8.07 (-6.99%)

08:34
12/06/19
12/06
08:34
12/06/19
08:34
Hot Stocks
Alexion says conducting proactive sales process not in best interest of holders »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 16

    Dec

SJI

South Jersey Industries

$30.69

0.2 (0.66%)

, DTE

DTE Energy

$125.33

0.07 (0.06%)

08:33
12/06/19
12/06
08:33
12/06/19
08:33
Hot Stocks
South Jersey Industries announces sale of Marina Thermal Facility for $100M »

SJI (SJI) announced it…

SJI

South Jersey Industries

$30.69

0.2 (0.66%)

DTE

DTE Energy

$125.33

0.07 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

KWR

Quaker Houghton

$152.06

1.01 (0.67%)

08:33
12/06/19
12/06
08:33
12/06/19
08:33
Conference/Events
Quaker Houghton to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

HOV

Hovnanian

$25.11

3.77 (17.67%)

08:32
12/06/19
12/06
08:32
12/06/19
08:32
Recommendations
Hovnanian analyst commentary  »

Hovnanian price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:30
12/06/19
12/06
08:30
12/06/19
08:30
General news
Breaking General news story  »

November nonfarm payrolls…

HD

Home Depot

$213.09

-1.04 (-0.49%)

08:30
12/06/19
12/06
08:30
12/06/19
08:30
Conference/Events
Home Depot to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 25

    Feb

ROAD

Construction Partners

$19.32

0.09 (0.47%)

, SEMG

SemGroup

$15.03

(0.00%)

08:30
12/06/19
12/06
08:30
12/06/19
08:30
Options
One new option listing and one option delisting on December 6th »

New option listings for…

ROAD

Construction Partners

$19.32

0.09 (0.47%)

SEMG

SemGroup

$15.03

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

AWK

American Water

$123.37

0.92 (0.75%)

08:28
12/06/19
12/06
08:28
12/06/19
08:28
Conference/Events
American Water to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.